Evidence map›Paper›PMID 35383193›Full record

ArticleNature communications2022

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.

Ezra Y Rosen, Helen H Won, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong, Noah D Friedman, Ino de Bruijn, Onur Sumer, Craig M Bielski and 22 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 2 institutions in 1 country.

Ezra Y Rosen *Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Helen H Won *Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Youyun ZhengDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4507-2708
Emiliano CoccoDepartment of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-1397-2656
Duygu SelcukluMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yixiao GongMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Noah D FriedmanDepartment of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ino de BruijnMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5427-4750
Onur SumerMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-9726-9441
Craig M BielskiDepartment of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Casey SavinMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Caitlin BourqueMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Christina FalconDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nikeysha ClarkeDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Xiaohong JingMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Fanli MengMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Catherine ZimelMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sophie ShifmanDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Srushti KittaneDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Fan WuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-3960-320X
Marc LadanyiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kevin EbataLoxo Oncology at Lilly, Stamford, CT, USA.
Jennifer KheraniLoxo Oncology at Lilly, Stamford, CT, USA.
Barbara J BrandhuberLoxo Oncology at Lilly, Stamford, CT, USA.
James FaginDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-2365-2517
Eric J ShermanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Natasha RekhtmanDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michael F BergerMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-3882-5000
Maurizio ScaltritiDepartment of Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David M HymanLoxo Oncology at Lilly, Stamford, CT, USA.ORCID http://orcid.org/0000-0001-8150-9762
Barry S Taylor *Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylor.lab.msk@gmail.com.
Alexander Drilon *Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. drilona@mskcc.org.ORCID http://orcid.org/0000-0001-6806-9061
Memorial Sloan Kettering Cancer Center · USLoxo Oncology at Lilly (United States) · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35383193
PMCPMC8983712
OpenAlexW4224320463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.